The national cost of asthma among school-aged children in the United States.
CONCLUSION: Childhood asthma continues to represent a prevalent and significant clinical and economic burden in the United States. More aggressive treatment and asthma management programs are needed to address this national financial and resource burden.
PMID: 28890020 [PubMed - in process]
Source: Annals of Allergy, Asthma and Immunology - Category: Allergy & Immunology Authors: Sullivan PW, Ghushchyan V, Navaratnam P, Friedman HS, Kavati A, Ortiz B, Lanier B Tags: Ann Allergy Asthma Immunol Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Children | Emergency Medicine | Health Management | Insurance | Medicaid | USA Health